Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #2951
Reference
Drug alert no 12/2009
Name
Drug alert no 12: class 2
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
EFFECTIVENESS
DRUG THERAPY
PHARMACEUTICAL SERVICES
PHARMACEUTICAL INDUSTRY
Description
GlaxoSmithKline UK (GSK) and MHRA are recalling all remaining stock of 25 micrograms of salmeterol xinafoate and 250 micrograms of fluticasone propionate per actuation batch due to the possible presence of counterfeit inhalers in the legitimate supply chain. Glaxo Wellcome UK Ltd are the marketing authorisation holder but this product is branded as an Allen and Hanburys item.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy Division, Primary and Community Care Directorate, St Andrew’s House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2009-05-12 00:00:00
Click to go back to homepage